Changes made in 2017 to the World Medical Association Physician’s Pledge strive to keep in step with geopolitical trends by addressing patient autonomy and collegiality.
AMA J Ethics. 2019;21(9):E796-800. doi:
10.1001/amajethics.2019.796.
Some commentators say comparative trials of FDA-approved drugs are overburdened by current Common Rule regulations and that researchers should not be required to obtain explicit consent for participation in the most innocuous of these trials.